Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Prostate cancer screening campaigns are giving men the finger

Gary Schwitzer
Conditions
October 22, 2018
Share
Tweet
Share

Fifty years ago, in a golden moment of television comedy shows, Rowan & Martin’s Laugh-In program regularly featured “The Flying Fickle Finger of Fate” award.  Wikipedia says it “recognized actual dubious achievements by public individuals or institutions.” Do a Google search.  You’ll quickly see how popular this award became.

Yes, I’m dating myself by going back 50 years.  But mine is the generation that often becomes obsessed with being given “the finger” by doctors for digital rectal exams (DRE) looking for prostate cancer.

And it is in that context that we propose to revive The Flying Fickle Finger of Fate award.  It could be awarded to prostate cancer screening promotions that deliver a new Laugh-In about prostate exams. While they are funny, it is no joke that they fail to educate men about the evidence that raises important questions about the DRE.  The following is what you will not learn in these promotional campaigns.

An UpToDate analysis states:

We suggest not performing digital rectal examination (DRE) for prostate cancer screening either alone or in combination with prostate-specific antigen (PSA) screening. Although DRE has long been used to diagnose prostate cancer, no controlled studies have shown a reduction in the morbidity or mortality of prostate cancer when detected by DRE at any age.

There are inherent limitations to the DRE. It can detect palpable abnormalities in the (areas) of the prostate gland where the majority of cancers arise; however, other areas of the prostate where cancer occurs are not reachable by a finger examination. Furthermore, the majority of cancers detected by DRE alone are clinically or pathologically advanced, and (early) stage T1 prostate cancers are nonpalpable by definition.

…there is no high-level evidence that DRE screening improves survival outcomes.

The author of that analysis is Richard Hoffman, MD, MPH, the director of the Division of General Internal Medicine at the University of Iowa Carver College of Medicine.  He wrote to me, “Even the American Urological Association, whose members are probably most adept at performing DREs, admits that evidence is insufficient to justify using DRE as a first-line screening test.”

A systematic review and meta-analysis of the evidence published in the Annals of Family Medicine this year concluded: “Given the considerable lack of evidence supporting its efficacy, we recommend against routine performance of DRE to screen for prostate cancer in the primary care setting.”

After years of going through the perfunctory DRE from my own doctor, I finally challenged him about the evidence.  That was a couple of years ago.  He hasn’t put the glove on to give me the finger ever since.

A new low for an awareness campaign that doesn’t raise awareness

Mike Rowe, TV host of Dirty Jobs (no comment), probably had good intentions when he taped a prostate awareness public service announcement. But the end result is no public service because it is filled with misinformation. It features Rowe getting a DRE from his own doctor. In the video, Rowe states that with early detection, the five-year survival rate for prostate cancer is nearly 100 percent. We’ve written about how such five-year survival rate stats are often misleading. Nearly 100%? I recall one observer saying about such a statistic, “Hmmm. Almost as if it’s not a cancer.”  Indeed, early detection with a PSA blood test – also discussed in the video – may mean finding something that would never harm a man in his lifetime but would still end up being treated. So if you’re detecting many things that won’t cause harm, the five-year survival rate is bound to look pretty impressive. Rowe’s doctor delivers concise, catchy, but totally misleading comments about the only two reasons why you should not do a DRE.  “One, the doctor doesn’t have a finger,” he says.  “And the other is if the patient doesn’t have a rectum.”  Yuck it up, then look it up to see evidence-based reasons why you may not want to have a DRE. Rowe compounds the problem by telling men they have “no excuse” not to get a DRE.  That kind of heavy-handed blame game is often employed in screening promotions.  It’s a wrong-headed approach.  Dr. Hoffman wrote to me: “Missing from the amusing video is the part where the doctor tells the patient that getting screened for prostate cancer is not a slam dunk decision.  There are benefits—and harms—to screening and men should be helped to make informed decisions that best reflect their values and preferences.”  In other words, a fully-informed shared decision making discussion between patient and physician is needed, not a “no excuse” mandate.

YouTube video

In Canada, the Prostate Cancer Canada organization has gone all-out with a “Famous Fingers” comedy approach to DRE.  It features famous fingers through time that could be employed in DREs.  Take your pick:  Beethoven, Big Foot, Paul Bunyan, Sherlock Holmes, Winston Churchill, Al Capone, Genghis Khan, Napoleon, Babe Ruth, Frankenstein’s monster.  The campaign is woefully void of evidence.

ADVERTISEMENT

Such campaigns are giving you the finger

In the end (no puns intended throughout), these campaigns do a disservice to uninformed men.  They generate laughs but present no evidence.  It’s an absurd way to conduct an awareness campaign.  It may raise awareness of the comical creativity of an advertising agency but does nothing to deliver the facts that men need to make an informed decision.

They’ve given you the finger, guys.  You can fight back by arming yourself with knowledge of the evidence. We’ve provided some highlights above. It doesn’t require a PhD to understand what the science shows and what it doesn’t.  If you still choose to pursue the DRE or the PSA blood test, more power to you.  At least you won’t be swayed by a rah-rah, single-minded promotional campaign on behalf of special interests who stand to gain by your business and by further fundraising.

Gary Schwitzer is a journalist and founder, HealthNewsReview.org.

Image credit: Shutterstock.com

Prev

The financial independence wild goose chase

October 22, 2018 Kevin 0
…
Next

We can do a better job with hospital discharge paperwork

October 23, 2018 Kevin 3
…

Tagged as: Mainstream media, Oncology/Hematology

Post navigation

< Previous Post
The financial independence wild goose chase
Next Post >
We can do a better job with hospital discharge paperwork

ADVERTISEMENT

More by Gary Schwitzer

  • Fact-checking faces steep challenges in health care

    Gary Schwitzer
  • a desk with keyboard and ipad with the kevinmd logo

    Cancer screening stories need to report on the uncertainties

    Gary Schwitzer
  • a desk with keyboard and ipad with the kevinmd logo

    Andrea Mitchell breast cancer thoughts

    Gary Schwitzer

Related Posts

  • When breast cancer screening guidelines conflict: Some patients face real consequences

    Leda Dederich
  • Hormone replacement therapy is still linked to cancer

    Martha Rosenberg
  • We have a shot at preventing cervical cancer

    Lisa N. Abaid, MD, MPH
  • Obstruction of medical justice: How health care fails patients with cancer

    Miriam A. Knoll, MD
  • Despite progress in cancer care, cost and equity challenges still must be addressed

    David M. Aboulafia, MD
  • Using the Avengers to explain how cancer treatments work

    Jennifer Lycette, MD

More in Conditions

  • What Elon Musk and Diddy reveal about the price of power

    Osmund Agbo, MD
  • Understanding depression beyond biology: the power of therapy and meaning

    Maire Daugharty, MD
  • Why medicine must stop worshipping burnout and start valuing humanity

    Sarah White, APRN
  • Why perinatal mental health is the top cause of maternal death in the U.S.

    Sheila Noon
  • A world without vaccines: What history teaches us about public health

    Drew Remignanti, MD, MPH
  • Unraveling the mystery behind one of the most dangerous pregnancy complications: preeclampsia

    Thomas McElrath, MD, PhD and Kara Rood, MD
  • Most Popular

  • Past Week

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why medical schools must ditch lectures and embrace active learning

      Arlen Meyers, MD, MBA | Education
    • Why public health must be included in AI development

      Laura E. Scudiere, RN, MPH | Tech
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
  • Recent Posts

    • Why medical schools must ditch lectures and embrace active learning

      Arlen Meyers, MD, MBA | Education
    • Why helping people means more than getting an MD

      Vaishali Jha | Education
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • Why evidence-based management may be an effective strategy for stronger health care leadership and equity

      Olumuyiwa Bamgbade, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • Residency match tips: Building mentorship, research, and community

      Simran Kaur, MD and Eva Shelton, MD | Education

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 4 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why medical schools must ditch lectures and embrace active learning

      Arlen Meyers, MD, MBA | Education
    • Why public health must be included in AI development

      Laura E. Scudiere, RN, MPH | Tech
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
  • Recent Posts

    • Why medical schools must ditch lectures and embrace active learning

      Arlen Meyers, MD, MBA | Education
    • Why helping people means more than getting an MD

      Vaishali Jha | Education
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • Why evidence-based management may be an effective strategy for stronger health care leadership and equity

      Olumuyiwa Bamgbade, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • Residency match tips: Building mentorship, research, and community

      Simran Kaur, MD and Eva Shelton, MD | Education

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Prostate cancer screening campaigns are giving men the finger
4 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...